Agnès Buzyn, minister of Health and Solidarity announces the 10 selected projects.
Jean-Christophe CORVOL, ICM team leader and neurologist (Sorbonne University, AP-HP) and Stanley DURRLEMAN, ICM team leader and coordinator of the neuroinformatics group (INRIA)
Two ICM researchers won the call for projects « Health Data Hub » launched by the Ministry of Health and Solidarity, with a collaborative project on Parkinson’s disease.
With the Villani report, the President of the Republic announced that Health would be a priority sector for the development of artificial intelligence. To this aim, a call for projects was launched last January by the ministry of Health and Solidarity to identify research which could beneficiate from the specific support of the Health Data Hub.
Selected by a jury composed of experts in health, research and artificial intelligence, 10 projects among 189 candidates will beneficiate from the specific support of the Health Data Hub.
The Health Data Hub platform, which facilitate interactions between health data producers, users and citizens, in high security conditions, is essential for the emergence of innovation in research.
Among the laureates, the NS-Park project, coordinated by Prof Jean-Christophe CORVOL, ICM team leader and neurologist (Sorbonne University, AP-HP) and Stanley DURRLEMAN, ICM team leader and coordinator of the neuroinformatics group (INRIA) in collaboration with Prof Florence TUBACH, epidemiologist at Pitié-Salpêtrière Hospital, Prof Olivier RASCOL and Dr Maryse LAPEYRE-MESTRE from Toulouse Hospital.
The main objective of the NS-Park project is to make available to neurologists, a predictive tool of individual disease trajectory on Parkinson’s disease patients, in order to set up appropriate preventive measures. The data of this important cohort of 20 000 individuals, followed-up in expert centers for Parkinson’s disease will be linked to data from the Système National des Données de Santé (SNDS, National Health Data System) to work on the global care of patients. Computational and artificial intelligence approaches will be developed to model the progression of the disease. The secondary aim is to evaluate the impact of comorbidities on the progression of the disease.
The clinical cohort NS-Park beneficiate from the support of ICM, FCRIN « French Clinical Research Infrastructure network », Inserm, APHP and France PARKINSON association.
“F-CRIN is an infractructure for the future facing today and tomorrow’s issues of clinical research” Vincent Diebolt, FCRIN Director